- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vineet Laboratories Ltd (VINL)
Vineet Laboratories Ltd stock price live, this page displays NSE VINL stock exchange data. View the VINL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vineet Laboratories Ltd real time stock price chart below.
What Is the Vineet Laboratories Ltd Stock Price Today?
The Vineet Laboratories Ltd stock price today is 42.75.
What Is the Stock Symbol for Vineet Laboratories Ltd?
The stock symbol for Vineet Laboratories Ltd is ""VINL.""
What Stock Exchange Does Vineet Laboratories Ltd Trade On?
Vineet Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Vineet Laboratories Ltd a Good Stock to Buy?
Determining whether Vineet Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VINL quote. (ISIN: INE505Y01010)
What Is the Vineet Laboratories Ltd Stock Price Today?
The Vineet Laboratories Ltd stock price today is 42.75.
What Is the Stock Symbol for Vineet Laboratories Ltd?
The stock symbol for Vineet Laboratories Ltd is ""VINL.""
What Stock Exchange Does Vineet Laboratories Ltd Trade On?
Vineet Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Vineet Laboratories Ltd a Good Stock to Buy?
Determining whether Vineet Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VINL quote. (ISIN: INE505Y01010)
42.75
+0.54(+1.28%)
Closed·
Fair Value
An estimate of a Vineet Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.01
44.66
52 wk Range
26.51
64.69
VINL Scorecard
Full Analysis
High shareholder yield
Unusual trading volume
1/2
Fair Value
An estimate of a Vineet Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.0144.66
52 wk Range
26.5164.69
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
VINL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Vineet Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Vineet Laboratories Ltd Company Profile
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.
Compare VINL to Peers and Sector
Metrics to compare | VINL | Peers Peers - average of corresponding metrics from companies closely matching VINL: MOREPENLAB, KOPRAN, 540694, 524790, BLUEJET | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVINLPeersSector |
|---|---|---|---|---|
P/E Ratio | −2.1x | 29.1x | −0.7x | |
PEG Ratio | 0.00 | 0.24 | 0.00 | |
Price/Book | 2.9x | 3.6x | 2.6x | |
Price / LTM Sales | 0.7x | 2.7x | 3.4x | |
Upside (Analyst Target) | - | 19.4% | 35.5% | |
Fair Value Upside | Unlock | 2.0% | 3.3% | Unlock |
Earnings
Latest Release
Jul 22, 2025
EPS / Forecast
-0.94 / --
Revenue / Forecast
74.60M / --
FAQ
What Stock Exchange Does Vineet Laboratories Trade On?
Vineet Laboratories is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Vineet Laboratories?
The stock symbol for Vineet Laboratories is "VINL."
What Is the Vineet Laboratories Market Cap?
As of today, Vineet Laboratories market cap is 394.11M.
What Is Vineet Laboratories's Earnings Per Share (TTM)?
The Vineet Laboratories EPS (TTM) is -20.53.
From a Technical Analysis Perspective, Is VINL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Vineet Laboratories Stock Split?
Vineet Laboratories has split 0 times.
How Many Employees Does Vineet Laboratories Have?
Vineet Laboratories has 57 employees.
What is the current trading status of Vineet Laboratories (VINL)?
As of 04 Oct 2025, Vineet Laboratories (VINL) is trading at a price of 42.75, with a previous close of 42.21. The stock has fluctuated within a day range of 42.01 to 44.66, while its 52-week range spans from 26.51 to 64.69.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.